Medicinal product name Portrazza
Pharmaceutical form Concentrate for solution for infusion
Strength 800 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.II onk. ķīm. ter.)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code L01FE03 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(800 mg/50 ml)
Glass vial    EU/1/15/1084/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/15/1084/001
Date of authorisation Feb 15, 2016
Marketing authorisation holder, country Eli Lilly Nederland B.V., Netherlands